{"entity":{"type":"insider","cik":"0001406836","url":"/insider/0001406836","json_url":"/insider/0001406836.json","name":"Schobel Alexander Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2018-11-26","last":"2024-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Schobel Alexander Mark","source":"filing","n_filings":11,"first_seen":"2018-11-26","last_seen":"2024-03-19"}],"transactions":[{"id":3077974,"accession":"0001214659-24-004795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-004795","line_url":"/filing/0001214659-24-004795#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":984476.0,"shares_owned_after_display":"984,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-19","scope":"insider"},{"id":2060614,"accession":"0001214659-24-004389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-24-004389","line_url":"/filing/0001214659-24-004389#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.1874,"price_display":"5.19","price_state":"stated","total_value":129685.0,"total_display":"129,685.00","total_whole":"129,685","shares_owned_after":1040371.0,"shares_owned_after_display":"1,040,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider"},{"id":6310985,"accession":"0001628280-22-016875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016875","line_url":"/filing/0001628280-22-016875#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45871.0,"shares_display":"45,871","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":44036.16,"total_display":"44,036.16","total_whole":"44,036","shares_owned_after":882871.0,"shares_owned_after_display":"882,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":4542028,"accession":"0001214659-21-001520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-001520","line_url":"/filing/0001214659-21-001520#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23460.0,"shares_display":"23,460","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":158355.0,"total_display":"158,355.00","total_whole":"158,355","shares_owned_after":837000.0,"shares_owned_after_display":"837,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":4542025,"accession":"0001214659-21-001520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-21-001520","line_url":"/filing/0001214659-21-001520#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11540.0,"shares_display":"11,540","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":77895.0,"total_display":"77,895.00","total_whole":"77,895","shares_owned_after":860460.0,"shares_owned_after_display":"860,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":4850510,"accession":"0001214659-21-001480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-21-001480","line_url":"/filing/0001214659-21-001480#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40792.0,"shares_display":"40,792","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":265148.0,"total_display":"265,148.00","total_whole":"265,148","shares_owned_after":872000.0,"shares_owned_after_display":"872,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":2085476,"accession":"0001214659-20-004314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-004314","line_url":"/filing/0001214659-20-004314#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":902113.0,"shares_owned_after_display":"902,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-11","scope":"insider"},{"id":3097054,"accession":"0001214659-20-003962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-003962","line_url":"/filing/0001214659-20-003962#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":1022113.0,"shares_owned_after_display":"1,022,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-29","filed_date":"2020-05-01","scope":"insider"},{"id":2693027,"accession":"0001214659-20-004018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-004018","line_url":"/filing/0001214659-20-004018#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":942113.0,"shares_owned_after_display":"942,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-05-04","scope":"insider"},{"id":2693019,"accession":"0001214659-20-004018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-004018","line_url":"/filing/0001214659-20-004018#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":3.7,"price_display":"3.70","price_state":"stated","total_value":148000.0,"total_display":"148,000.00","total_whole":"148,000","shares_owned_after":982113.0,"shares_owned_after_display":"982,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-14","filed_date":"2020-05-04","scope":"insider"},{"id":6544219,"accession":"0001140361-18-044950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-044950","line_url":"/filing/0001140361-18-044950#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":7780.0,"total_display":"7,780.00","total_whole":"7,780","shares_owned_after":1019624.0,"shares_owned_after_display":"1,019,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-11","scope":"insider"},{"id":6850264,"accession":"0001140361-18-044870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-044870","line_url":"/filing/0001140361-18-044870#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.69,"price_display":"8.69","price_state":"stated","total_value":17380.0,"total_display":"17,380.00","total_whole":"17,380","shares_owned_after":1018624.0,"shares_owned_after_display":"1,018,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-10","scope":"insider"},{"id":6511702,"accession":"0001140361-18-043656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-043656","line_url":"/filing/0001140361-18-043656#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001406836","owner_name":"Schobel Alexander Mark","owner_display_name":"Schobel Alexander Mark","owner_url":"/insider/0001406836","role":"Officer (Chief Innovation/Tech Officer)","role_mark":"O","role_mark_label":"Officer (Chief Innovation/Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Innovation/Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":10250.0,"total_display":"10,250.00","total_whole":"10,250","shares_owned_after":1009229.0,"shares_owned_after_display":"1,009,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2018-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Officer (Chief Innovation/Tech Officer)","n_filings":11,"first_seen":"2018-11-26","last_seen":"2024-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001406836","retrieved_at":"2026-08-24T14:50:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}